Epidemiology and pharmacogenetics

1 – 10 of 54

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/v1001091?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
5
6
next »

2024
Mark Potential interplay between tumor size and vitamin D receptor (VDR) polymorphisms in breast cancer prognosis : a prospective cohort study
Lindgren, Hampus ^LU ; Ademi, David ^LU ; Godina, Christopher ^LU ; Tryggvadottir, Helga ^LU ; Isaksson, Karolin ^LU and Jernström, Helena ^LU (2024) In Cancer Causes and Control 35(6). p.907-919
- Contribution to journal › Article
Mark High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
Godina, Christopher ^LU ; Khazaei, Somayeh ^LU ; Belting, Mattias ^LU ; Vallon-Christersson, Johan ^LU ; Nodin, Björn ^LU ; Jirström, Karin ^LU ; Isaksson, Karolin ^LU ; Bosch, Ana ^LU and Jernström, Helena ^LU (2024) In PLoS ONE 19(7). p.1-21
- Contribution to journal › Article
Mark The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study
Huss, Linnea ^LU ; Gulz-Haake, Igis ^LU ; Nilsson, Emma ^LU ; Tryggvadottir, Helga ^LU ; Nilsson, Linn ^LU ; Nodin, Björn ^LU ; Jirström, Karin ^LU ; Isaksson, Karolin ^LU and Jernström, Helena ^LU (2024) In Nutrients 16(7). p.1-15
- Contribution to journal › Article
Mark Into the twilight zone – should ER-low breast cancer be treated as triple negative breast cancer?
Jernström, Helena ^LU and Rydén, Lisa ^LU (2024) In The Lancet Regional Health - Europe 40.
- Contribution to journal › Debate/Note/Editorial
Mark Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
Godina, Christopher ^LU ; Belting, Mattias ^LU ; Vallon-Christersson, Johan ^LU ; Isaksson, Karolin ^LU ; Bosch, Ana ^LU and Jernström, Helena ^LU (2024) In Scientific Reports 14(1).
- Contribution to journal › Article
Mark Understanding the genetic complexity of puberty timing across the allele frequency spectrum
Kentistou, K.A. ; Jernström, H. ^LU and Ong, Ken K. (2024) In Nature Genetics 56(7). p.1397-1411
- Contribution to journal › Article
Mark Germline copy number variants and endometrial cancer risk
Stylianou, Cassie E. ; Wiggins, George A.R. ; Lau, Vanessa L. ; Dennis, Joe ; Shelling, Andrew N. ; Wilson, Michelle ; Sykes, Peter ; Amant, Frederic ; Annibali, Daniela and De Wispelaere, Wout , et al. (2024) In Human Genetics 143(12). p.1481-1498
- Contribution to journal › Article
Mark Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients
Nilsson, Linn ^LU ; Khazaei, Somayeh ^LU ; Tryggvadottir, Helga ^LU ; Björner, Sofie ^LU ; Bressan, Alessandra ; Jirström, Karin ^LU ; Adrian, Gabriel ^LU ; Falck, Anna-Karin ^LU ; Borgquist, Signe ^LU and Isaksson, Karolin ^LU , et al. (2024) In Clinical Breast Cancer 24(3). p.152-166
- Contribution to journal › Article
Mark Targeting IGF-IR improves neoadjuvant chemotherapy efficacy in breast cancers with low IGFBP7 expression
Godina, Christopher ^LU ; Pollak, Michael N. and Jernström, Helena ^LU (2024) In NPJ precision oncology 8(1).
- Contribution to journal › Article
Mark A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor
Faraj Tabrizi, Schayan ; Mei, Wenbin ; Godina, Christopher ^LU ; Lovisa, Anthea F. ; Isaksson, Karolin ^LU ; Jernström, Helena ^LU and Tavazoie, Sohail F. (2024) In Cell p.1-19
- Contribution to journal › Article

« previous
1
2
3
4
5
6
next »